{"id":"W2061761565","doi":"10.1007/s11102-013-0539-4","title":"Pasireotide monotherapy in Cushing’s disease: a single-centre experience with 5-year extension of phase III Trial","year":2013,"lang":"en","type":"article","venue":"Pituitary","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôtel-Dieu de Montréal; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Novartis Pharma; Sanofi; Canadian Society of Endocrinology and Metabolism; Eli Lilly and Company; Society for Endocrinology; Novartis","keywords":"Pasireotide; Medicine; Cushing's disease; Adverse effect; Clinical trial; Internal medicine; Tolerability; Disease; Surgery; Acromegaly","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003284461,0.001089796,0.002764785,0.0002838003,0.0006154378,0.001275651,0.0008055078,0.001202051,0.001906875],"category_scores_gemma":[0.001426234,0.0003100628,0.002026552,0.0004882016,0.000858813,0.001190786,0.0002987036,0.002637249,0.0006809014],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001098105,"about_ca_system_score_gemma":0.001264355,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002598129,"about_ca_topic_score_gemma":0.005101757,"domain_scores_codex":[0.9991831,0.0003359957,0.00004928905,0.000117615,0.00008735531,0.0002266296],"domain_scores_gemma":[0.9989457,0.0003269702,0.0001083423,0.000117999,0.00007995711,0.0004211467],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4831811,0.03156978,0.01548315,0.001309002,0.003896252,0.001688654,0.001800098,0.01032741,0.05176057,0.001072607,0.009862506,0.3880489],"study_design_scores_gemma":[0.4463672,0.4600925,0.06787141,0.0002418327,0.00153256,0.001938239,0.0003542956,0.004083398,0.005831125,0.0008671244,0.01065043,0.0001698721],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.986526,0.007306382,0.0009996947,0.0006609449,0.0002080261,0.0006095557,0.0007169206,0.00008879168,0.002883574],"genre_scores_gemma":[0.9908709,0.002890174,0.00145517,0.0007231395,0.0001154389,0.0005296119,0.001710613,0.00003851908,0.001666445],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003284461,"threshold_uncertainty_score":0.01737005,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02207781473165354,"score_gpt":0.2754599877746958,"score_spread":0.2533821730430423,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}